DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Rhinosinusitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Rhinosinusitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rhinosinusitis development. The report provides detailed ...
January 2020
60 pages
Rhinovirus Infection - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Rhinovirus Infection - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rhinovirus Infection development. The report provides ...
January 2020
60 pages
Schistosomiasis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Schistosomiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Schistosomiasis development. The report provides detailed ...
January 2020
60 pages
Sciatic Pain - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Sciatic Pain - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sciatic Pain development. The report provides ...
January 2020
60 pages
Seasonal Allergic Rhinitis - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Seasonal Allergic Rhinitis The report also ...
January 2020
60 pages
Secondary Hyperparathyroidism - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Secondary Hyperparathyroidism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Secondary Hyperparathyroidism development. The report provides ...
January 2020
60 pages
Sedation - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Sedation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sedation development. The report provides detailed ...
January 2020
60 pages
Seizures - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Seizures - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Seizures development. The report provides detailed ...
January 2020
60 pages
Sensory Neuropathy - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Sensory Neuropathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sensory Neuropathy development. The report provides ...
January 2020
60 pages
Septic Shock - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Septic Shock - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Septic Shock development. The report provides ...
January 2020
60 pages
Severe Psoriasis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Severe Psoriasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Severe Psoriasis development. The report provides ...
January 2020
120 pages
Shigella Infections - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Shigella Infections - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Shigella Infections development. The report provides ...
January 2020
60 pages
Sickle Cell Disease - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Sickle Cell Disease The report also ...
January 2020
60 pages
Sinusitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Sinusitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sinusitis development. The report provides detailed ...
January 2020
60 pages
Sleep Apnea - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Sleep Apnea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Sleep Apnea development. The report provides ...
January 2020
60 pages
Smallpox - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Smallpox - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Smallpox development. The report provides detailed ...
January 2020
60 pages
Smoking Cessation - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Smoking Cessation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Smoking Cessation development. The report provides ...
January 2020
60 pages
Spasticity - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Spasticity - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Spasticity development. The report provides detailed ...
January 2020
120 pages
Status Epilepticus - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Status Epilepticus - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Status Epilepticus development. The report provides ...
January 2020
60 pages
Substance (Drug) Abuse - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Substance (Drug) Abuse The report also ...
January 2020
60 pages
Surgical Wound Infections - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Surgical Wound Infections The report also ...
January 2020
60 pages
Systemic Lupus Erythematosus - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Systemic Lupus Erythematosus The report also ...
January 2020
60 pages
Systemic Mastocytosis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Systemic Mastocytosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Systemic Mastocytosis development. The report provides ...
January 2020
60 pages
Tardive Dyskinesia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Tardive Dyskinesia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tardive Dyskinesia development. The report provides ...
January 2020
60 pages
Thrombocytopenia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Thrombocytopenia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Thrombocytopenia development. The report provides detailed ...
January 2020
60 pages
